Investors Chronicle

Join us now

Mark Robinson

How long will the bears be with us?

With the bear market in its infancy, it may pay to delay your return to the buyers' circle

Mark Robinson

Beat volatility and build on the down leg

Markets are retreating in the face of an invisible enemy – fear. Now is the time to plan for the eventual shift in sentiment

Mark Robinson

Silence Therapeutics gets into in bed with AstraZeneca

Silence Therapeutics gets into in bed with AstraZeneca

Some thoughts on post-apocalyptic capital allocations

The oil price dominates, but we may need to abandon some prevailing investment assumptions in the wake of Covid-19

Mark Robinson

Ferguson on track with demerger

Ferguson on track with demerger

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office